Koers ICON PLC Irish S.E.
Aandelen
ICLR
IE0005711209
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 8,64 mld. 7,97 mld. | Omzet 2025 * | 9,3 mld. 8,57 mld. | Marktkapitalisatie | 26,86 mld. 24,76 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 827 mln. 763 mln. | Nettowinst (verlies) 2025 * | 1 mld. 923 mln. | EV/omzet 2024 * | 3,37 x |
Nettoschuld 2024 * | 2,27 mld. 2,1 mld. | Nettoschuld 2025 * | 1,17 mld. 1,08 mld. | EV/omzet 2025 * | 3,01 x |
K/w-verhouding 2024 * |
32,4
x | K/w-verhouding 2025 * |
26,5
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,35% |
Recentste transcriptie over ICON PLC
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Cutler
CEO | Chief Executive Officer | 63 | 01-11-11 |
Brendan Brennan
DFI | Director of Finance/CFO | 45 | 01-01-06 |
Ciaran Murray
CHM | Chairman | 61 | 03-10-05 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Climax
FOU | Founder | 71 | 01-06-90 |
Stephen Cutler
CEO | Chief Executive Officer | 63 | 01-11-11 |
Linda Grais
BRD | Director/Board Member | 68 | 01-07-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. | |
-11,83% | 10,74 mld. |